Where can I learn more about this study?
You can find more information about this study on the websites listed below.
> www.clinicaltrials.gov. Once you are on the website, type “NCT03906045”
into the search box and click “Search”.
www.AstraZenecaClinicalTrials.com. Once you are on the website, type
>
“D5980C00020” into the search box, and click “Find a Study”.
Full Study Title: A Phase I, Single-Dose, Gamma Scintigraphy Study to Assess
the Pulmonary Deposition of Technetium-99m Radiolabeled Budesonide,
Glycopyrronium and Formoterol Fumarate MDI Following a Maximal Breath-
Hold of up to 10 seconds in Patients with Moderate to Severe/Very Severe
Chronic Obstructive Pulmonary Disease
AstraZeneca Protocol Number: D5980C00020
AstraZeneca sponsored this study and has its headquarters at 1800 Concord
Pike in Wilmington, Delaware
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Participants in clinical studies belong to a large community of
people who take part in clinical research around the world.
They help researchers answer important health questions and
find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting
participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_05_21
8 | Clinical Study Results